IEC 60601-2-5 specifies the particular requirements for the basic safety and essential performance of ultrasonic physiotherapy equipment. IEC 60601-2-5 testing supplements IEC 60601-1 and must be applied in conjunction with the general standard and applicable collateral standards. ITC India Pvt Ltd We are just a call away + 91-9316473033
For manufacturers and regulatory consultants, understanding this standard is critical for CE marking, FDA submissions, and global market access. https://webstore.iec.ch/en/publication/2668

Regulatory Position of IEC 60601-2-5 in the 60601 Framework
IEC 60601-2-5 is a particular standard, meaning it modifies or replaces clauses of:
- IEC 60601-1 (General Safety)
- IEC 60601-1-2 (EMC)
- IEC 60601-1-6 (Usability)
- IEC 60601-1-8 (Alarms, if applicable)
- ISO 14971 (Risk Management – mandatory integration)
Where conflicts exist, IEC 60601-2-5 takes precedence.IEC 60601 Testing. Elevate your electro-medical devices standards

Scope and Device Classification Considerations
This standard applies to:
- Therapeutic ultrasound devices
- Continuous and pulsed output systems
- Physiotherapy ultrasound equipment used in clinical environments
Regulatory consultants must confirm:
- Intended use alignment
- Device classification (EU MDR / FDA)
- Energy output thresholds
- Applicator configuration
Misclassification may result in non-compliance during technical file review.https://www.iso.org/standard/72704.html
Basic Safety Requirements – Design & Verification Focus
Electrical Safety IEC-60601-2-5-testing
Manufacturers must demonstrate:
- Compliance with leakage current limits
- Protection against electric shock (MOOP/MOPP requirements)
- Adequate insulation coordination
- Safe power supply design
Testing must follow IEC 60601-1 baseline criteria.https://en.wikipedia.org/wiki/IEC_60601
Acoustic Output Control
Critical compliance parameters include:
- Ultrasonic frequency accuracy
- Effective radiating area (ERA)
- Beam non-uniformity ratio (BNR)
- Output power tolerance
- Maximum intensity limits
Uncontrolled output presents risk of thermal injury and tissue damage.EMC Testing
Thermal and Mechanical Safety
Verification must include:
- Transducer surface temperature limits
- Mechanical robustness of applicators
- Prevention of unintended continuous emission
- Fail-safe design in case of control malfunction

Essential Performance – Risk-Based Interpretation
Under IEC 60601-2-5, essential performance relates to:
The ability of the ultrasonic physiotherapy equipment to deliver therapeutic energy within specified tolerances without causing unacceptable risk.
Manufacturers must define:
- Essential output parameters
- Acceptable performance deviation thresholds
- Failure conditions that may lead to harm
- Monitoring and protective mechanisms
Regulatory consultants should ensure essential performance is clearly documented in the Risk Management File (RMF).
Integration with ISO 14971 Risk Management
IEC 60601-2-5 requires full integration with ISO 14971.
Key documentation must include:
- Hazard analysis (thermal injury, cavitation effects, electrical hazards)
- Risk estimation and control measures
- Verification of risk control effectiveness
- Residual risk evaluation
- Benefit-risk analysis
Notified Bodies increasingly scrutinize essential performance linkage to risk controls.EMI/EMC for Medical Devices
Testing & Verification Strategy
Manufacturers should prepare for:
- Acoustic power measurement
- Beam profile analysis
- Output stability testing
- Temperature rise testing
- Leakage current testing
- Mechanical durability testing
- EMC testing (IEC 60601-1-2)
Testing must be traceable, calibrated, and documented in accordance with QMS requirements (ISO 13485).
Technical Documentation Requirements (EU MDR Perspective)
For CE marking, documentation must include:
- General Safety and Performance Requirements (GSPR) mapping
- Standards compliance matrix
- Test reports from accredited laboratory
- Risk Management File
- Usability engineering file
- Clinical evaluation (where applicable)
- Post-market surveillance planning
IEC 60601-2-5 compliance alone does not ensure CE marking — it must be integrated into the full regulatory strategy.
FDA Considerations (US Market)
For 510(k) submissions:
- Identify predicate device
- Demonstrate substantial equivalence
- Provide performance testing data
- Address software validation (if applicable)
- Provide acoustic output verification
FDA may request additional performance data depending on output characteristics.
Common Compliance Gaps Identified by Notified Bodies
- Poor definition of essential performance
- Incomplete risk linkage to acoustic hazards
- Missing BNR validation
- Inadequate temperature testing
- Insufficient traceability in technical file
Proactive gap assessment reduces approval delays.
Strategic Compliance Approach for Manufacturers
Recommended pathway:
- Define intended use and classification
- Perform risk analysis early in design phase
- Identify applicable clauses of IEC 60601-2-5
- Conduct pre-compliance testing
- Perform full accredited laboratory testing
- Compile regulatory documentation
- Conduct internal audit before submission
Early compliance integration significantly reduces redesign risk.
Conclusion
IEC 60601-2-5 is a critical standard governing the safe therapeutic delivery of ultrasonic energy. For manufacturers and regulatory consultants, successful compliance requires a structured, risk-based, and documentation-driven approach aligned with global regulatory frameworks.
Strategic implementation ensures:
- Safer products
- Faster approvals
- Reduced regulatory queries
- Stronger global market positioning
